Cognitive impairment and dementia in Parkinson's disease: practical issues and management.
Identifieur interne : 000631 ( Main/Exploration ); précédent : 000630; suivant : 000632Cognitive impairment and dementia in Parkinson's disease: practical issues and management.
Auteurs : Murat Emre [Turquie] ; Paul J. Ford ; Ba Ar Bilgiç ; Ergun Y. UçSource :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2014.
English descriptors
- KwdEn :
- Animals, Automobile Driving, Cognition (physiology), Cognition Disorders (physiopathology), Cognition Disorders (psychology), Cognition Disorders (therapy), Dementia (etiology), Dementia (physiopathology), Dementia (psychology), Dementia (therapy), Humans, Parkinson Disease (complications), Parkinson Disease (diagnosis), Parkinson Disease (physiopathology), Parkinson Disease (therapy).
- MESH :
- complications : Parkinson Disease.
- diagnosis : Parkinson Disease.
- etiology : Dementia.
- physiology : Cognition.
- physiopathology : Cognition Disorders, Dementia, Parkinson Disease.
- psychology : Cognition Disorders, Dementia.
- therapy : Cognition Disorders, Dementia, Parkinson Disease.
- Animals, Automobile Driving, Humans.
Abstract
Cognitive impairment and dementia pose particular challenges in the management of patients with Parkinson's disease (PD). Decision-making capacity can render patients vulnerable in a way that requires careful ethical considerations by clinicians with respect to medical decision making, research participation, and public safety. Clinicians should discuss how future decisions will be made as early in the disease course as possible. Because of cognitive, visual, and motor impairments, PD may be associated with unsafe driving, leading to early driving cessation in many. DBS of the STN and, to a lesser degree, globus pallidus interna (GPi) has consistently been associated with decreased verbal fluency, but significant global cognitive decline is usually not observed in patients who undergo rigorous selection. There are some observations suggesting lesser cognitive decline in GPi DBS than STN DBS, but further research is required. Management of PD dementia (PDD) patients involves both pharmacological and nonpharmacological measures. Patients with PDD should be offered treatment with a cholinesterase inhibitor taking into account expected benefits and potential risks. Treatment with neuroleptics may be necessary to treat psychosis; classical neuroleptics, as well as risperidone and olanzapine, should be avoided. Quetiapine might be considered first-line treatment because it does not need special monitoring, although the strongest evidence for efficacy exists for clozapine. Evidence from randomized, controlled studies in the PDD population is lacking; selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors may be used to treat depressive features. Clonazepam or melatonin may be useful in the treatment of rapid eye movement behavior disorder.
DOI: 10.1002/mds.25870
PubMed: 24757114
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000525
- to stream PubMed, to step Curation: 000525
- to stream PubMed, to step Checkpoint: 000648
- to stream Ncbi, to step Merge: 003F74
- to stream Ncbi, to step Curation: 003F74
- to stream Ncbi, to step Checkpoint: 003F74
- to stream Main, to step Merge: 000631
- to stream Main, to step Curation: 000631
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cognitive impairment and dementia in Parkinson's disease: practical issues and management.</title>
<author><name sortKey="Emre, Murat" sort="Emre, Murat" uniqKey="Emre M" first="Murat" last="Emre">Murat Emre</name>
<affiliation wicri:level="1"><nlm:affiliation>Istanbul University, Istanbul Faculty of Medicine, Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Istanbul, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Istanbul University, Istanbul Faculty of Medicine, Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Istanbul</wicri:regionArea>
<wicri:noRegion>Istanbul</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ford, Paul J" sort="Ford, Paul J" uniqKey="Ford P" first="Paul J" last="Ford">Paul J. Ford</name>
</author>
<author><name sortKey="Bilgic, Ba Ar" sort="Bilgic, Ba Ar" uniqKey="Bilgic B" first="Ba Ar" last="Bilgiç">Ba Ar Bilgiç</name>
</author>
<author><name sortKey="Uc, Ergun Y" sort="Uc, Ergun Y" uniqKey="Uc E" first="Ergun Y" last="Uç">Ergun Y. Uç</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="doi">10.1002/mds.25870</idno>
<idno type="RBID">pubmed:24757114</idno>
<idno type="pmid">24757114</idno>
<idno type="wicri:Area/PubMed/Corpus">000525</idno>
<idno type="wicri:Area/PubMed/Curation">000525</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000648</idno>
<idno type="wicri:Area/Ncbi/Merge">003F74</idno>
<idno type="wicri:Area/Ncbi/Curation">003F74</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003F74</idno>
<idno type="wicri:Area/Main/Merge">000631</idno>
<idno type="wicri:Area/Main/Curation">000631</idno>
<idno type="wicri:Area/Main/Exploration">000631</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Cognitive impairment and dementia in Parkinson's disease: practical issues and management.</title>
<author><name sortKey="Emre, Murat" sort="Emre, Murat" uniqKey="Emre M" first="Murat" last="Emre">Murat Emre</name>
<affiliation wicri:level="1"><nlm:affiliation>Istanbul University, Istanbul Faculty of Medicine, Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Istanbul, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Istanbul University, Istanbul Faculty of Medicine, Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Istanbul</wicri:regionArea>
<wicri:noRegion>Istanbul</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ford, Paul J" sort="Ford, Paul J" uniqKey="Ford P" first="Paul J" last="Ford">Paul J. Ford</name>
</author>
<author><name sortKey="Bilgic, Ba Ar" sort="Bilgic, Ba Ar" uniqKey="Bilgic B" first="Ba Ar" last="Bilgiç">Ba Ar Bilgiç</name>
</author>
<author><name sortKey="Uc, Ergun Y" sort="Uc, Ergun Y" uniqKey="Uc E" first="Ergun Y" last="Uç">Ergun Y. Uç</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Automobile Driving</term>
<term>Cognition (physiology)</term>
<term>Cognition Disorders (physiopathology)</term>
<term>Cognition Disorders (psychology)</term>
<term>Cognition Disorders (therapy)</term>
<term>Dementia (etiology)</term>
<term>Dementia (physiopathology)</term>
<term>Dementia (psychology)</term>
<term>Dementia (therapy)</term>
<term>Humans</term>
<term>Parkinson Disease (complications)</term>
<term>Parkinson Disease (diagnosis)</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Parkinson Disease (therapy)</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Dementia</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Cognition</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Cognition Disorders</term>
<term>Dementia</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Cognition Disorders</term>
<term>Dementia</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Cognition Disorders</term>
<term>Dementia</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Automobile Driving</term>
<term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Cognitive impairment and dementia pose particular challenges in the management of patients with Parkinson's disease (PD). Decision-making capacity can render patients vulnerable in a way that requires careful ethical considerations by clinicians with respect to medical decision making, research participation, and public safety. Clinicians should discuss how future decisions will be made as early in the disease course as possible. Because of cognitive, visual, and motor impairments, PD may be associated with unsafe driving, leading to early driving cessation in many. DBS of the STN and, to a lesser degree, globus pallidus interna (GPi) has consistently been associated with decreased verbal fluency, but significant global cognitive decline is usually not observed in patients who undergo rigorous selection. There are some observations suggesting lesser cognitive decline in GPi DBS than STN DBS, but further research is required. Management of PD dementia (PDD) patients involves both pharmacological and nonpharmacological measures. Patients with PDD should be offered treatment with a cholinesterase inhibitor taking into account expected benefits and potential risks. Treatment with neuroleptics may be necessary to treat psychosis; classical neuroleptics, as well as risperidone and olanzapine, should be avoided. Quetiapine might be considered first-line treatment because it does not need special monitoring, although the strongest evidence for efficacy exists for clozapine. Evidence from randomized, controlled studies in the PDD population is lacking; selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors may be used to treat depressive features. Clonazepam or melatonin may be useful in the treatment of rapid eye movement behavior disorder.</div>
</front>
</TEI>
<affiliations><list><country><li>Turquie</li>
</country>
</list>
<tree><noCountry><name sortKey="Bilgic, Ba Ar" sort="Bilgic, Ba Ar" uniqKey="Bilgic B" first="Ba Ar" last="Bilgiç">Ba Ar Bilgiç</name>
<name sortKey="Ford, Paul J" sort="Ford, Paul J" uniqKey="Ford P" first="Paul J" last="Ford">Paul J. Ford</name>
<name sortKey="Uc, Ergun Y" sort="Uc, Ergun Y" uniqKey="Uc E" first="Ergun Y" last="Uç">Ergun Y. Uç</name>
</noCountry>
<country name="Turquie"><noRegion><name sortKey="Emre, Murat" sort="Emre, Murat" uniqKey="Emre M" first="Murat" last="Emre">Murat Emre</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000631 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000631 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:24757114 |texte= Cognitive impairment and dementia in Parkinson's disease: practical issues and management. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:24757114" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
This area was generated with Dilib version V0.6.23. |